Drugs@FDA: FDA Approved Drug Products

Home | Previous Page

Abbreviated New Drug Application (ANDA): 206543
Company: AUROBINDO PHARMA LTD
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
IPRATROPIUM BROMIDE IPRATROPIUM BROMIDE 0.02% SOLUTION;INHALATION Prescription AN No No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
10/27/2016 ORIG-1 Approval STANDARD

Label is not available on this site.

IPRATROPIUM BROMIDE

SOLUTION;INHALATION; 0.02%
TE Code = AN

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
IPRATROPIUM BROMIDE IPRATROPIUM BROMIDE 0.02% SOLUTION;INHALATION Prescription No AN 206543 AUROBINDO PHARMA LTD
IPRATROPIUM BROMIDE IPRATROPIUM BROMIDE 0.02% SOLUTION;INHALATION Prescription No AN 077072 LANDELA PHARM
IPRATROPIUM BROMIDE IPRATROPIUM BROMIDE 0.02% SOLUTION;INHALATION Prescription No AN 075562 NEPHRON
IPRATROPIUM BROMIDE IPRATROPIUM BROMIDE 0.02% SOLUTION;INHALATION Prescription No AN 075693 RITEDOSE CORP
IPRATROPIUM BROMIDE IPRATROPIUM BROMIDE 0.02% SOLUTION;INHALATION Prescription No AN 207903 SUN PHARM
IPRATROPIUM BROMIDE IPRATROPIUM BROMIDE 0.02% SOLUTION;INHALATION Prescription No AN 076291 WATSON LABS

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English